Sangamo Therapeutics Inc. buy Truist Financial Co.
Start price
15.08.23
/
50%
€0.93
Target price
15.08.24
€6.40
Performance (%)
-13.17%
End price
16.08.24
€0.81
Summary
This prediction ended on 16.08.24 with a price of €0.81. The price of Sangamo Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.17%. Truist_Financial_Co_ has a follow-up prediction for Sangamo Therapeutics Inc. where he still thinks Sangamo Therapeutics Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Sangamo Therapeutics Inc. | -5.499% | -5.499% | -83.600% |
| iShares Core DAX® | -0.793% | 4.201% | 19.951% |
| iShares Nasdaq 100 | -2.376% | 0.857% | 4.704% |
| iShares Nikkei 225® | -2.701% | -0.147% | 12.609% |
| iShares S&P 500 | -1.689% | 1.244% | 3.144% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Sangamo Bioscienes diskutieren
Sangamo Therapeutics, Inc. (NASDAQ: SGMO) had its price target lowered by analysts at Truist Financial Co. from $8.00 to $7.00. They now have a "buy" rating on the stock.
Ratings data for SGMO provided by MarketBeat
In the thread Trading Sangamo Bioscienes
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.12
23.01.25
23.01.25
€4.80
23.01.26
23.01.26
-67.80%
08:09
08:09
Stopped prediction by Truist_Financial_Co_ for Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc.
Start price
Target price
Perf. (%)
€2.04
13.12.24
13.12.24
€6.66
13.12.25
13.12.25
-81.30%
14.12.25
14.12.25